Plain-English translation of NCT06626113 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Researchers want to understand why people with obesity sometimes have higher blood pressure and increased nerve activity even without a formal high blood pressure diagnosis. This study tests whether , a common vitamin supplement, might help reduce this nerve overactivity. You would receive either the medication or a placebo (a dummy pill) across two separate study visits.
People with obesity often show signs of an overactive nervous system that can raise blood pressure, but researchers don't fully understand why this happens or how to treat it. This trial is testing whether this medication might help calm that overactivity and prevent future heart and blood vessel problems.
You likely qualify if…
You likely don't qualify if…
You will visit the laboratory three times over five weeks. At your first visit, you'll be screened and have blood tests. At visits two and three (about three weeks apart), you'll receive either or placebo in random order—neither you nor the researchers will know which one you're getting. The study involves standard blood pressure checks and blood draws to measure how your nervous system responds.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States